The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
[EN] HCV NS3 PROTEASE INHIBITORS<br/>[FR] INHIBITEURS DE LA PROTÉASE NS3 DU VHC
申请人:MERCK SHARP & DOHME
公开号:WO2013074386A3
公开(公告)日:2015-06-18
US9328138B2
申请人:——
公开号:US9328138B2
公开(公告)日:2016-05-03
HCV NS3 protease inhibitors
申请人:Merck Sharp & Dohme Corp.
公开号:US09328138B2
公开(公告)日:2016-05-03
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.